About Us
Tahota (Hong Kong) Law Firm, LLP (Tahota Hong Kong Office), located at Room 1202, 12F, Tower 1, Lippo Centre, 89 Queensway, Hong Kong, China,was registered with the approval of the Law Society of Hong Kong on July 22, 2016 and officially opened on August 24, 2016. There are 4 certified attorneys (3 partners), and they all graduated from well-known universities in Mainland China, Hong Kong China, the United States and the United Kingdom with master's degrees. We are committed to providing high-quality and efficient cross-border legal services for clients in different regions with Hong Kong as the hub.
Boasting with internationalized professional talents, highly efficient legal business environment, convenient and fast global transportation, abundant and open financial markets and simple tax regime with low tax rate, Hong Kong has been rated as the most freedom economic entity in the world by the Heritage Foundation for 24 consecutive years. At the same time, Hong Kong Special Administrative Region, as the only region where Common Law is applied in China, has a unique legal and economic status in the field of international finance and trade, cross-border investment, and international commercial dispute settlement during the course of China's reform and opening up as well as the implementation of the Belt and Road Initiative.
Through the "document notarization and certification business", "bond, trust and fund business", "Hong Kong and offshore company operation business", "international investment and trade business" and "international commercial dispute resolution business" of our Hong Kong Office , we can provide Hong Kong local businessmen, overseas businessmen doing businesses in the mainland via Hong Kong, and mainland businessmen doing businesses in Hong Kong or overseas via Hong Kong engaged in all kinds of commercial transactions with high-quality international professional legal services.
Since its establishment, Tahota Hong Kong Office has undertaken a number of relevant businesses with the affiliate, including but not limited to the international commercial arbitration of a dispute over the exclusive distribution right of an Italian drug in mainland China, the trading platform disputes between an Australian enterprise and a Chinese e-commerce company, restructuring of a well-known Japanese enterprise's Chinese joint venture, acquisition of a New Zealand Internet Company by a Hong Kong investment institution, and establishment of an overseas operating platform by a mainland Internet enterprise.
